One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-146003
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 6 |
Affiliation: Ospedale Papa Giovanni XXIII, Medical University of Silesia, National Institute of Emergency Medicine "Pirogov", Karyopharm Therapeutics (United States), Institute of Blood Pathology and Transfusion Medicine of the National Academy of Medical Sciences of Ukraine, University of Melbourne, St Vincent's Hospital, Cancer Institute (WIA), Indira Gandhi Institute of Medical Sciences, Theageneio General Hospital, Inserm, Centre Hospitalier Universitaire de Poitiers, University of Poitiers, Jagiellonian University, General University Hospital in Prague, Imperial College Healthcare NHS Trust, University of Belgrade, City Clinical Hospital, University of Perugia, Nil Ratan Sircar Medical College and Hospital, Medical College and Hospital, Kolkata, Vall d'Hebron Hospital Universitari, Flinders University, Flinders Medical Centre, Leicester Royal Infirmary, Baylor University Medical Center, Nantes Université, Medical University of Lodz, Icahn School of Medicine at Mount Sinai, King's College Hospital NHS Foundation Trust, Evangelismos Hospital, Medical University Plovdiv, The Royal Wolverhampton NHS Trust, Dana-Farber Cancer Institute, Harvard University, University of Ostrava, University Hospital Ostrava, Federal Almazov North-West Medical Research Centre, National and Kapodistrian University of Athens, Alexandra Hospital, University of Maryland, Baltimore, University of Alberta, National Cancer Institute, Norton HealthcareClinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
